Advisory Committee on the Medical Uses of Isotopes: Meeting Notice

Issuing agencies

Abstract

The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 20-21, 2026. A sample of agenda items to be discussed include: a review of recent medical events; recommendations and advice to support the NRC implementation of the ADVANCE Act; recommendations on the staff's memo for licensing the use of alpha nuclides in radiopharmaceutical therapy; recommendations on the potential applications of artificial intelligence (AI) and deep learning technologies to enhance the efficiency and effectiveness of the NRC medical staff and the ACMUI; recommended best practices for the preparation of reports, including guidance on writing subcommittee reports and developing effective presentations, including Commission presentations; assessment of ACMUI membership to determine if the ACMUI would like to propose a change in membership to include an interventional radiologist; ACMUI review and recommendations regarding staff's proposed rulemaking on modernizing requirements relating to physical protection of category 1 and category 2 quantities of radioactive material rulemaking (topic is tentative based on its rulemaking schedule); and NRC's medical radiation safety team updates.